Trisalus Life Sciences, Inc.
TLSI
Revenue
13.21M
▲1.64M▲14.17%
3 Months ChangeAssets
35.33M
▼-1.13M▼-3.10%
3 Months ChangeLiabilities
69.19M
▲6.00M▲9.50%
3 Months ChangeFree Cash Flow
-5.25M
▲5.68M▲51.95%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-05
Form 8-K
ID: 0001628280-26-015155
2026-02-20
Form 8-K
ID: 0001493152-26-007598
2026-02-09
Form 8-K
ID: 0001628280-26-006219
2026-01-12
Form 8-K
ID: 0001628280-26-001743
2025-11-13
Form 10-Q
ID: 0001628280-25-052043
2025-11-13
Form 8-K
ID: 0001628280-25-052008
2025-10-01
Form 8-K
ID: 0001628280-25-043440
2025-08-29
Form 8-K
ID: 0001826667-25-000129
2025-08-12
Form 10-Q
ID: 0001826667-25-000117
2025-08-12
Form 8-K
ID: 0001826667-25-000115